These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer. Kim Y, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY. Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780 [Abstract] [Full Text] [Related]
3. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma. Rohde M, Nielsen AL, Pareek M, Johansen J, Sørensen JA, Diaz A, Nielsen MK, Christiansen JM, Asmussen JT, Nguyen N, Gerke O, Thomassen A, Alavi A, Høilund-Carlsen PF, Godballe C. J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144 [Abstract] [Full Text] [Related]
10. The role of thorax imaging in staging head and neck squamous cell carcinoma. Ong TK, Kerawala CJ, Martin IC, Stafford FW. J Craniomaxillofac Surg; 1999 Dec; 27(6):339-44. PubMed ID: 10870751 [Abstract] [Full Text] [Related]
11. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial. Senft A, de Bree R, Hoekstra OS, Kuik DJ, Golding RP, Oyen WJ, Pruim J, van den Hoogen FJ, Roodenburg JL, Leemans CR. Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977 [Abstract] [Full Text] [Related]
12. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA. Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136 [Abstract] [Full Text] [Related]
15. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma. Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY. Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365 [Abstract] [Full Text] [Related]
17. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Fleming AJ, Smith SP, Paul CM, Hall NC, Daly BT, Agrawal A, Schuller DE. Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315 [Abstract] [Full Text] [Related]
19. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Wang HM, See LC, Chen TM, Kang CJ, Wu YF, Lin KJ, Liao CT. J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350 [Abstract] [Full Text] [Related]